Our finding that Blimp-1+Gzmbhi TRM cells can be generated from TRM cells isolated from tolerant allografts is in line with these previous reports and suggests that specifically targeting intragraft TRM cells may be a viable strategy for preventing BOS. Here, PRDM1 is linked to Buschke-Ollendorff syndrome.